Fulvestrant and endocarditis noninfective Patient Reports February 12, 2012

Fulvestrant Side Effects Report #4587290-X
Fulvestrant side effect was reported by a Consumer or non-health professional from on Feb 01, 2005. Female patient, 75 years of age, weighting 117.9 lb, was diagnosed with breast cancer  and was treated with Fulvestrant. After drug was administered, patient experienced the following side effects: cerebral artery occlusion, cerebral infarction, depressed level of consciousness, disease recurrence, dizziness , endocarditis noninfective, febrile neutropenia, hemiplegia. Fulvestrant dosage: 500 MG IM. During the same period patient was treated with ADRIACIN, ENDOXAN, DECADRON, NAUZELIN, KYTRIL. Patient was hospitalized and became disabled. Patient died on 09/09/2004.